Beverly Hills Private Wealth’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-11,556
| Closed | -$103K | – | 343 |
|
|
2025
Q1 | $103K | Buy |
11,556
+327
| +3% | +$2.9K | 0.02% | 332 |
|
|
2024
Q4 | $154K | Sell |
11,229
-1,627
| -13% | -$22.3K | 0.03% | 326 |
|
|
2024
Q3 | $352K | Sell |
12,856
-2,791
| -18% | -$76.4K | 0.07% | 244 |
|
|
2024
Q2 | $383K | Sell |
15,647
-1,150
| -7% | -$28.1K | 0.08% | 229 |
|
|
2024
Q1 | $358K | Sell |
16,797
-804
| -5% | -$17.1K | 0.08% | 249 |
|
|
2023
Q4 | $337K | Sell |
17,601
-2,086
| -11% | -$39.9K | 0.09% | 236 |
|
|
2023
Q3 | $316K | Sell |
19,687
-19,648
| -50% | -$315K | 0.09% | 221 |
|
|
2023
Q2 | $760K | Buy |
39,335
+20,099
| +104% | +$388K | 0.12% | 178 |
|
|
2023
Q1 | $447K | Buy |
19,236
+3,631
| +23% | +$84.3K | 0.14% | 158 |
|
|
2022
Q4 | $226K | Buy |
+15,605
| New | +$226K | 0.1% | 204 |
|